In this study, we further confirmed that the BACE2 variants identified from HSCR patients were loss-of-function mutations, and the hPSC-derived BOs carrying these variants exhibited AD-like phenotypes, including Aβ accumulation and neuronal cell death. The gene discussed is BACE2; the disease is Alzheimer disease.